Navigation Links
Lung Cancer May Be Deadlier for Men
Date:11/13/2008

Gender is the major socioeconomic factor influencing outcomes, study finds

THURSDAY, Nov. 13 (HealthDay News) -- Men are more likely to die from inoperable non-small cell lung cancer than women, U.S. researchers report.

In fact, gender is the most important factor influencing overall survival of patients with this disease, the new study found.

A team of researchers in six U.S. cities studied 1,365 patients enrolled in national group trials to determine the effect of such sociodemographic factors as gender, race and marital status on lung cancer outcomes.

They found that men had a 1.23 times higher death rate than women, while race and marital status didn't significantly affect outcomes.

"Our study corroborates the fact that gender plays an important role as a prognostic factor in people diagnosed with lung cancer," the lead author, Dr. Benjamin Movsas, chair of the radiation oncology department at Henry Ford Hospital in Detroit, said in a news release. "This underscores the importance of studying this disease entity in light of the fact that women diagnosed with lung cancer tend to have a better outcome in terms of survival."

The study was to be presented Thursday at the Chicago Multidisciplinary Symposium in Thoracic Oncology.

At the same meeting, another group of U.S. researchers, from the South West Oncology Group, reported that a combination of traditional chemotherapy with targeted therapies called monoclonal antibodies was safe and improved survival of patients with advanced non-small cell lung cancer.

The study found that the use of two targeted therapies (bevacizumab and cetuximab) with chemotherapy (carboplatin and paclitaxel) as first-line treatment improved the survival of 104 patients who were evaluated between August 2006 and September 2007. There were no safety concerns.

"The combination of multiple targeted therapies in addition to chemotherapy may be the future of treatment in lung cancer," lead author Dr. Edward Kim, an assistant professor in the department of thoracic/head and neck medical oncology at M.D. Anderson Cancer Center in Houston, said in a news release. "Blocking more key cancer pathways such as the epidermal growth factor receptor and vascular endothelial growth factor may lead to improved cancer control."

In 2008, about 215,000 new cases of lung cancer will be diagnosed in the United States and 161,840 people will die from the disease, according to the U.S. National Cancer Institute.

More information

The American Cancer Society has more about non-small cell lung cancer.



-- Robert Preidt



SOURCE: American Society for Therapeutic Radiology and Oncology, news releases, Nov. 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer treatment may result in bone loss
2. American Academy of Dermatology: Stop Skin Cancer On The Spot
3. Gender is key factor in determining overall survival of lung cancer patients
4. Proton therapy may reduce serious side effect of lung cancer treatment
5. Tissue analyses indicate survival benefits for some lung cancer patients
6. Advanced lung cancer patients see improved, progression-free survival
7. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
8. Research demonstrates differing genetic makeup of lung cancer in African-American patients
9. Novel 4-drug combination proves safe for lung cancer treatment
10. US Oncology Applauds Senator Baucuss Healthcare Reform Call to Action for 2009, Supports Collaborative Measures to Enhance Cancer Patients Access to Care While Improving Quality and Access
11. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Cancer May Be Deadlier for Men
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
(Date:12/9/2016)... ... 09, 2016 , ... The Holy Name Medical Center Foundation ... on December 3rd, to benefit Holy Name Medical Center's programs and services. More ... over $1 million - the largest event in the Center's history, both in ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to get ... thought that if the nebulizer had a more child-friendly design, then children would be ... developed the patent-pending NEBY to avoid the need to deliver medication via a nebulizer ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices Market Outlook to 2022", provides ... Devices market. The report provides value, in millions ... prices (USD) within market segement - Glaucoma Drainage ... and distribution shares data for each of these ...
(Date:12/8/2016)... 2016 KEY FINDINGS The global ... 2017-2023. Various reasons for growth of the medical lifting ... of chronic diseases, high recovery cost of injuries and ... Medical lifting sling refers to an assistive device that ... slings connect to the lift and hold the patient. ...
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
Breaking Medicine Technology: